SCHEMBL29907100

SCHEMBL29907100

C=Cc1cc2c(nc1-c1cccc3c1CCC3)c(-c1cnn(C)c1)nn2COCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210784 1.00
SCHEMBL23211053 0.93
SCHEMBL29907065 0.93
SCHEMBL29907197 0.89 CNR1 (0.34)
SCHEMBL23211133 0.89 CNR1 (0.34)
SCHEMBL29008870 0.76 GPR84 (0.33)
SCHEMBL23264127 0.74 MAP4K1 (0.46)
SCHEMBL23211081 0.72 DGAT1 (0.31)
SCHEMBL29907092 0.72 DGAT1 (0.31)
SCHEMBL23210897 0.70 AXL (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115835908-A Bicyclic heterocycles as FGFR inhibitors 因赛特公司 2023-03-21 CN disclosed
EP-4045151-A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2022-08-24 EP disclosed